UPenn — Philadelphia, Pennsylvania

UPenn is a clinical research site located in Philadelphia, Pennsylvania, United States 19106.

Crixeo Clinical Trials Trust Score: 21/100 (FAILING). This profile has not yet been claimed by the site owner.

UPenn has participated in 20 clinical trials with 6 currently active.

Therapeutic areas: Soft Tissue Sarcoma, Dyslipidemias, Autism Spectrum Disorder.

Sponsors: Polaris Group, NewAmsterdam Pharma, Health Resources and Services Administration (HRSA).

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Philadelphia

Browse all research sites in Pennsylvania · View every site in Philadelphia

Sponsor Feasibility Report

Trust Score: 21/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for UPenn?

UPenn has a Crixeo Trust Score of 21/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has UPenn conducted?

UPenn has 20 clinical trials on record, with 6 currently active. Their work covers Soft Tissue Sarcoma, Dyslipidemias, Autism Spectrum Disorder.

Is UPenn accredited by Crixeo Clinical Trials?

UPenn has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about UPenn?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.